DUSTIN GOSSER: Open Payments
NPI 1245886274 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 28 payments from 12 companies in 2025. Trend: 2023 $729 · 2024 $846 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $125 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Amgen Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $29 |
| RADIOMETER AMERICA, INC | 1 | $22 |
Products named: UBRELVY, TRELEGY ELLIPTA, OTEZLA, Ozempic, VRAYLAR, HETLIOZ, Cologuard Collection Kit, TREMFYA.
Industry payments across KY — which companies pay providers there.
